Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Cell-permeable PI3 kinase competitive peptide inhibits KIT mutant mediated tumorigenesis of gastrointestinal stromal tumor (GIST).
Mol Biol Rep. 2024 Jan 11;51(1):98. doi: 10.1007/s11033-023-09120-x.
Mol Biol Rep. 2024.
PMID: 38206538
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.
Li S, Zhao S, Liang N, Zhang S, Zhang L, Zhou L, Liu A, Cao X, Tian J, Yu Y, Fan Z, Xiao K, Wang M, Zhao H, Bai R, Sun J.
Li S, et al.
Gastric Cancer. 2023 Sep;26(5):677-690. doi: 10.1007/s10120-023-01402-4. Epub 2023 May 24.
Gastric Cancer. 2023.
PMID: 37222910
Item in Clipboard
MiR-19a-3p Promotes Aerobic Glycolysis in Ovarian Cancer Cells via IGFBP3/PI3K/AKT Pathway.
Du L, Dou K, Zhang D, Xia H, Liang N, Wang N, Sun J, Bai R.
Du L, et al.
Folia Biol (Praha). 2023;69(5-6):163-172. doi: 10.14712/fb2023069050163.
Folia Biol (Praha). 2023.
PMID: 38583177
Free article.
Item in Clipboard
Cite
Cite